Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses

BACKGROUND: Efficacy of inhaled loxapine 5 or 10 mg in treating agitation was shown using the Positive and Negative Syndrome Scale – Excited Component (PANSS-EC) in two Phase III randomised, double-blind, placebo-controlled trials in 344 agitated patients with schizophrenia and 314 patients with bip...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeller, Scott, Zun, Leslie, Cassella, James V., Spyker, Daniel A., Yeung, Paul P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal College of Psychiatrists 2017
Materias:
Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680528/
https://www.ncbi.nlm.nih.gov/pubmed/29163985
http://dx.doi.org/10.1192/bjpo.bp.117.005363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680528/
https://www.ncbi.nlm.nih.gov/pubmed/29163985
http://dx.doi.org/10.1192/bjpo.bp.117.005363

Ejemplares similares